latest news releases from the newsroom
Pacific Sunwear of California, Inc.
Pacific Sunwear to Present at Piper Jaffray 26th Annual Consumer Conference
ANAHEIM, Calif., June 2, 2006 (PRIMEZONE) -- Pacific Sunwear of California, Inc. (Nasdaq:PSUN), is scheduled to present at the Piper Jaffray 26th Annual Consumer Conference at The Palace Hotel in New York on Wednesday, June 7, 2006 at 9:00 AM/EST. Pacific Sunwear (PacSun) will be represented at the conference by Seth Johnson, Chief Executive Officer and Gerry Chaney, Sr. Vice President and Chief Financial Officer.
Stewart, Archibald & Barney, LLP Implements iLumen's Client Financial Monitoring and Benchmarking Service
ATLANTA, June 2, 2006 (PRIMEZONE) -- Stewart, Archibald & Barney, LLP, a leading CPA firm in Las Vegas, Nevada, and iLumen, Inc. jointly announced today that Stewart, Archibald & Barney will implement iLumen's client financial monitoring and benchmarking service. Implementing iLumen's service will further position Stewart, Archibald & Barney as a firm focused on delivering added value to help their accounting, auditing and consulting business clients reach their long-term goals.
First Equity Group
StockMarketNewsAlert.com Announces Corporate Profile on GTC Biotherapeutics, Inc.
POMPANO BEACH, Fla., June 2, 2006 (PRIMEZONE) -- GTC Biotherapeutics, Inc. ("GTC") (Nasdaq:GTCB) is new to StockMarketNewsAlert.com. According to M. D'Alonzo the company recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion on the market authorization application (MAA) for ATryn(r), GTC's recombinant form of human antithrombin. The CHMP has recommended that ATryn(r) be granted market authorization for the prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency. ATryn(r) may be given in association with heparin or low molecular weight heparin in these situations. The CHMP opinion recommends granting market authorization under the EMEA's procedures for exceptional circumstances. Final market authorization by the European Commission is expected in about three months. The positive CHMP opinion followed a defined process this week that included a review of GTC's submission of the grounds supporting re-examination of the previous opinion as well as a review of responses to specific questions posed by the CHMP to an independent expert panel composed of internationally recognized experts in the fields of hematology and hemostasis. These review activities are an integral part of the regulatory process for re-examination of a prior opinion.
Sell Rating for Cisco From DonHarrold.net
SHREVEPORT, La., June 2, 2006 (PRIMEZONE) -- DonHarrold.net (IARD No. 119079, http://www.donharrold.net), rates Cisco Systems Inc. (Nasdaq:CSCO), DIAMONDS Trust Series ETF (AMEX:DIA), Chesapeake Energy Corp (NYSE:CHK), and Bellsouth Corp (NYSE:BLS).
Buy Rating for Yahoo From DonHarrold.net
SHREVEPORT, La., June 2, 2006 (PRIMEZONE) -- DonHarrold.net (IARD No. 119079, http://www.donharrold.net), rates Yahoo! Inc. (Nasdaq:YHOO), Marvell Technology Group (Nasdaq:MRVL), Starbucks Corporation (Nasdaq:SBUX), and Activision Inc. (Nasdaq:ATVI).